查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197144

疝氣網狀設備市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Hernia Mesh Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，疝氣網片設備市場的複合年增長率預計為 4.3%。

COVID-19 對市場增長產生了重大影響，因為在大流行期間全球實施了突然和嚴格的封鎖。 此外，對 COVID-19 緊急護理的關注導致患者就診次數減少、疝氣手術推遲以及疝氣患者出現並發症。 例如，美國國家生物技術信息中心（NCBI）2022年9月發表的一篇論文發現，大流行的爆發減少了選擇性疝氣手術的數量，主要是切口疝氣手術，導致疝氣數量下降在鎖定開始時進行手術。三個月的時間 然而，隨著 2020 年 5 月之後 COVID-19 限制的逐步解除，腹股溝疝手術的數量激增。 例如，NCBI 在 2022 年 5 月發表的一項研究發現，大約 43.0% 的患者在限制後期間在腹股溝疝修補手術中存活下來，6.6% 經歷了坐月子，6.6% 去了急診室。據說這是15.2%。 因此，隨著全球疝氣修復手術數量的顯著增加，COVID-19的爆發對其前身的市場增長產生了負面影響，預計將繼續推動市場。

全世界疝氣的高患病率、治療疝氣的手術數量激增以及在 3D 網格開發中採用生物材料正在推動所研究市場的增長。是推動市場增長的主要因素之一 例如，根據美國國家衛生統計中心 2022 年的報告，美國每年有超過 500 萬人患有疝氣。 引起疝氣的主要因素包括人口老齡化、便秘、吸煙引起的慢性咳嗽、早產率高等。 此外，近年來，治療疝氣的手術數量激增。 例如，根據 2022 年 8 月發表在 NCBI 上的一篇論文，腹股溝疝是最常見的類型，美國每年進行的腹股溝疝手術超過 80 萬例。 這些因素正在推動採用網狀裝置治療疝氣，並被認為有助於市場的增長。

此外，在過去幾年中，在開髮用於疝氣修復的三維網格中，各種可生物降解聚合物的採用激增。 例如，根據 2022 年 2 月在 NCBI 上發表的一篇文章，許多可生物降解的聚合物正被用於製造醫療設備，例如植入物和三維網格。 生物可降解聚合物的生物活性和生物相容性可以與下一代技術和細胞療法相結合，以促進組織再生和受損組織的癒合。 因此，在三維網片開發中採用生物材料有望在全球範圍內加速疝氣網片設備市場的發展並在未來增加，從而推動預測期內所研究市場的增長。

疝氣補片市場趨勢

預計生物網部分在預測期內將出現顯著增長

生物網主要由豬和人的真皮發展而來。 與合成網相比，它有幾個優點，例如沒有感染風險，可用於污染區域。 例如，美國整形外科學會 Wolters Kluwer Health, Inc. 於 2022 年 2 月發表的一篇文章指出，用於腹疝修復的合成網片與手術部位感染、瘺管形成、腹部僵硬和粘連有關。這樣的 開發了生物網格來解決這些問題。 如今，強烈建議在感染風險高和污染程度高的情況下使用。 因此，由於生物網與合成纖維網相比具有多種優勢，預計該領域在預測期內將實現高速增長。

此外，與其他類型相比，使用強化生物綿羊腸 (RBOR) 網片的疝氣復發率明顯較低，因此在進行疝氣手術時採用率很高。 例如，2022 年 2 月發表在 NCBI 上的一項研究發現，與接受強化生物毛的患者相比，接受交聯豬細胞真皮基質 (C-PADM) 網片的患者發生並發症和疝氣復發的風險高 52.9% (RBOR)，只有 16.7%。 因此，在疝氣治療中採用 RBOR 正在推動這一領域的發展。

預計北美將主導疝氣補片裝置市場

北美受到疝氣高發、該地區疝氣修復手術數量多以及美國採用機器學習模型預測不良事件等因素的影響。,有望佔領市場。 根據美國外科醫師學會 (ACS) 2022 年 4 月的公告，美國每年進行 400 萬例腹部手術，其中一些需要疝修補術。 因此，預計該地區正在進行的大量疝氣修復手術將在預測期內推動該地區的增長。

此外，在美國採用 ML 模型預測疝氣復發也推動了區域市場的增長。 例如，2022 年 4 月，德克薩斯大學 MD 安德森癌症中心宣布推出 ML 模型，可以輕鬆預測術後疝氣復發和其他並發症。 在接受腹疝手術的患者中，ML 模型顯示出以□□下準確性。 預計疝氣復發率為 85%，手術部位發生率為 72%，30 天再入院率為 84%。 因此，疝氣手術的數量和先進模型的採用預計將推動該地區疝氣網狀裝置市場的需求。

因此，由於上述因素，北美地區的研究市場有望增長。

疝氣補片市場的競爭對手分析

由於多家公司在全球和區域開展業務，疝氣網片設備市場呈現碎片化。 競爭格局佔有市場份額，包括著名的 Medtronic PLC、Ethicon、B. Brown SE、Becton、Dickinson and Co.、WL Gore & Associates, Inc.、AbbVie、Getinge AB、Cook Medical，包括一些分析Integra LifeSciences 和 Dipromed SRL 等國際和本地公司。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 在疝修補術中採用網片的人數激增
    • 疝氣患病率增加
    • 網格技術進步
  • 市場製約因素
    • 網格成本高
    • 存在疝網裝置的替代品
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按疝氣類型
    • 腹股溝疝
    • 切口疝
    • 股疝
    • 其他疝氣類型
  • 按網格類型
    • 生物網
    • 合成網布
  • 按網格材料
    • 吸收網
    • 非吸水網布
  • 按用戶
    • 醫院
    • 門診手術中心
    • 診所
  • 按地區細分
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Medtronic Plc
    • Ethicon Inc.
    • B. Braun SE
    • Becton, Dickinson and Co.
    • W. L. Gore & Associates, Inc.
    • AbbVie Inc.
    • Getinge AB.
    • Cook Medical
    • Integra LifeSciences
    • Dipromed Srl

第7章 市場機會與今後動向

簡介目錄
Product Code: 92810

The hernia mesh devices market is expected to register a CAGR of 4.3% over the forecast period.

Due to the sudden implementation of stringent lockdowns throughout the world during the pandemic, COVID-19 had a substantial impact on the market's growth. Additionally, due to the primary focus on emergency COVID-19 treatments, there were fewer patient visits, and hernia surgeries were postponed, leading to complications in patients suffering from hernias. For instance, according to the article published by National Center for Biotechnology Information (NCBI) in September 2022, the onset of the pandemic resulted in a reduction in the number of elective hernia surgeries, mainly the incisional hernia surgery, with the first three months of lockdown having the most significant impact. However, due to the gradual lifting of COVID-19 restrictions after May 2020, there was a surge in the number of inguinal hernia surgeries. For instance, as per the study published by NCBI in May 2022, approximately 43.0% of the patients endured inguinal hernia repair surgeries, 6.6% experienced incarceration, and 15.2% had an emergency department encounter during the post-cancellation period. Thus, the COVID-19 outbreak affected the market's growth adversely in its preliminary phase; however, the market is expected to gain traction due to the significant increase in the number of hernia repair surgeries globally.

The high prevalence of hernia all over the world, the surging number of surgeries being performed for the treatment of hernias, and the employment of biomaterials in three-dimensional mesh development are among the major factors driving the growth of the market studied. For instance, according to the National Center for Health Statistics report 2022, more than five million people in the United States suffer from hernia every year. The major factors causing hernia are the high geriatric population, constipation, chronic cough due to smoking, and high premature birth rates. In addition, in recent years, there has been a surge in the number of surgeries performed to treat hernia. For instance, according to the article published in NCBI in August 2022, inguinal hernia is the most commonly occurring type of hernia and over 800,000 inguinal hernia surgeries are performed every year in the United States. Such factors are likely to boost the adoption of hernia mesh devices, thereby contributing to the market studied's growth.

Moreover, in the recent few years, there has been a surge in the employment of different biodegradable polymers for the development of three-dimensional meshes for hernia treatment. For instance, as per the article published in NCBI in February 2022, numerous biodegradable polymers are used to create medical devices, including implants and three-dimensional meshes. The bioactive and biocompatible qualities of biodegradable polymers, when combined with next-generation technologies and cell-based therapies, can advance tissue regeneration and the healing of damaged or injured tissue. Therefore, the adoption of biomaterials for three-dimensional mesh development is expected to accelerate the hernia mesh devices market globally and to increase in the future, thereby driving the growth of the market studied over the forecast period.

Hernia Mesh Devices Market Trends

Biologic Mesh Segment is Expected to Witness Significant Growth Over the Forecast Period

Biologic mesh is mainly developed from the porcine or human dermis. It offers several advantages over synthetic ones, including its high ability to be used in a contaminated area without the fear of infection. For instance, as per the article published in the American Society of Plastic Surgeons Wolters Kluwer Health, Inc. in February 2022, the synthetic meshes used for ventral hernia repair treatment led to several infections at the surgical site, fistula formation, abdominal stiffness, and adhesion. In order to address these issues, biological meshes were developed. More recently, they have been strongly recommended for use when infection risk is elevated, and contamination levels are high. Thus, due to the several benefits associated with the aid of biological meshes over synthetic ones, the segment is expected to register high growth during the forecast period.

Additionally, the recurrence rate of hernia is significantly less with the use of reinforced biologic ovine rumen (RBOR) mesh compared to the other types, leading to its high adoption while performing hernia surgeries. For instance, as per the study published in NCBI in February 2022, the risk of complications and hernia recurrence was higher in patients receiving cross-linked porcine acellular dermal matrices (C-PADM) mesh, i.e., 52.9%, in comparison to the ones receiving reinforced biologic ovine rumen (RBOR), i.e., only 16.7%. Thus, the adoption of RBOR for hernia treatment is augmenting the segment growth.

North America is Expected to Dominate the Hernia Mesh Devices Market

North America is expected to dominate the market owing to factors such as the high prevalence of hernias, the high number of hernia repair surgeries being performed in the region, and the adoption of machine learning models in the United States for the prediction of adverse events. As per the American College of Surgeons (ACS) in April 2022, in the United States, there are four million abdominal procedures performed annually, some of which may require hernia repair. Thus, the high number of hernia repair surgeries being performed in the region is expected to drive regional growth during the forecast period.

In addition, the adoption of ML models for the prediction of hernia recurrence in the United States is also burgeoning the regional market growth. For instance, in April 2022, the University of Texas MD Anderson Cancer Center announced the launch of an ML model, which can easily predict hernia recurrence and other complications post-surgery. In the patients who had been through ventral hernia surgery, the ML model showed the following accuracy rates: 85% for forecasting hernia recurrence, 72% for forecasting surgical site occurrence, and 84% for forecasting 30-day hospital readmission. Thus, the surgical number of hernia incidence and adoption of advanced models is expected to drive the demand for hernia mesh devices market in the region.

Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.

Hernia Mesh Devices Market Competitor Analysis

The hernia mesh devices market is fragmented due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known, including Medtronic Plc, Ethicon Inc., B. Braun SE, Becton, Dickinson and Co., W. L. Gore & Associates, Inc., AbbVie Inc., Getinge AB., Cook Medical, Integra LifeSciences, Dipromed SRL, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Surging Adoption of Mesh in Hernia Repair
    • 4.2.2 Increasing Prevalence of Hernia
    • 4.2.3 Technological Advancements in Mesh
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Meshes
    • 4.3.2 Presence of Substitutes in Hernia Mesh Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Hernia Type
    • 5.1.1 Inguinal Hernia
    • 5.1.2 Incisional Hernia
    • 5.1.3 Femoral Hernia
    • 5.1.4 Other Hernia Types
  • 5.2 By Mesh Type
    • 5.2.1 Biologic Mesh
    • 5.2.2 Synthetic Mesh
  • 5.3 By Mesh Material
    • 5.3.1 Absorbable Mesh
    • 5.3.2 Non-Absorbable Mesh
  • 5.4 By End-User
    • 5.4.1 Hospitals
    • 5.4.2 Ambulatory Surgical Centers
    • 5.4.3 Clinics
  • 5.5 By Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic Plc
    • 6.1.2 Ethicon Inc.
    • 6.1.3 B. Braun SE
    • 6.1.4 Becton, Dickinson and Co.
    • 6.1.5 W. L. Gore & Associates, Inc.
    • 6.1.6 AbbVie Inc.
    • 6.1.7 Getinge AB.
    • 6.1.8 Cook Medical
    • 6.1.9 Integra LifeSciences
    • 6.1.10 Dipromed Srl

7 MARKET OPPORTUNITIES AND FUTURE TRENDS